1. Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2015.174
Figure 3 Selection of induction and maintenance therapy for patients with severe proliferative lupus nephritis
Figure 3 | Selection of induction and maintenance therapy for patients with severe proliferative lupus nephritis. Multiple disease-related and patient-related factors affect the choice of therapy, among which perhaps the most important are ethnicity, histological class, disease severity and chronicity, renal function at presentation, and previous treatment responses. Although not shown, treatment costs, the patient's age and sex are additional factors that also need to be taken into account. AZA, azathioprine; CKD, chronic kidney disease; CYC, cyclophosphamide; MMF, mycophenolate mofetil; TAC, tacrolimus.
Mok, C. C. (2015) Towards new avenues in the management of lupus glomerulonephritis
Nat. Rev. Rheumatol. doi: /nrrheum